Document is current
Any future updates will be listed below
-
Authors
Lu, Yin
Wen, Yanlin
Feng, Sha
Huang, Wenting
-
Funding
Funding for this research was provided by:
Supported by Shenzhen High-level Hospital Construction Fund
Sponsored by National Cancer Center/National Clinical Research Center for Cancer/Cancer Hospital & Shenzhen Hospital，Chinese Academy of Medical Sciences and Peking Union Medical College，Shenzhen (E010522006)
- License Information
-
More Information
Article History
Received: 28 February 2024
Accepted: 20 June 2024
First Online: 9 July 2024
Declarations
:
: We state that the human subjects using in the study were approved by Independent Ethics Committee of the Chinese Academy of Medical Sciences and Peking Union Medical College. We conduct clinical trials in accordance with the provisions of the research protocol under the premise of complying with the National Health Commission's "Measures for the Ethical Review of Biomedical Research Involving Humans" and other laws and regulations. We provided a copy of the protocol and all relevant information to the investigators participating in this clinical trial under our leadership.
: The authors declare no competing interests.
